References
- Keating , G. M. and Lyseng‐Williamson , K. A. 2005 . Tolcapone: a review of its use in the management of Parkinson's disease . CNS Drugs , 19 : 165 – 184 .
- Borges , N. 2003 . Tolcapone‐related liver dysfunction: implications for use in Parkinson's disease therapy . Drug Saf. , 26 : 743 – 747 .
- Borgulya , J. , Bruderer , H. , Bernauer , K. , Zürcher , G. and DaPrada , M. 1989 . Catechol‐O‐methyltransferase‐inhibiting pyrocatechol derivatives: synthesis and structure‐activity studies . Helv. Chim. Acta , 72 : 952 – 968 .
- Bäckström , R. , Honkanen , E. , Pippuri , A. , Kairisalo , P. , Pystynen , J. , Heinola , K. , Nissinen , E. , Linden , I. , Männistö , P. T. , Kaakkola , S. and Pohto , P. 1989 . Synthesis of some novel potent and selective catechol O‐methyltransferase inhibitors . J. Med. Chem. , 32 : 841 – 846 .
- Pérez , R. A. , Fernández‐Alvarez , E. , Nieto , O. and Piefrafita , F. J. 1992 . Dihydroxynitrobenzaldehydes and hydroxymethoxynitrobenzaldehydes: synthesis and biological activity as catechol‐O‐methyltransferase inhibitors . J. Med. Chem. , 35 : 4584 – 4588 .
- Learmonth , D. A. and Freitas , A. P. 2002 . Chemical synthesis and characterization of conjugates of a novel catechol‐O‐methyltransferase inhibitor . Bioconjugate Chem. , 13 : 1112 – 1118 .
- Smith , K. S. , Smith , P. L. , Heady , T. N. , Trugman , J. M. , Harman , W. D. and Macdonald , T. L. 2003 . In vitro metabolism of tolcapone to reactive intermediates: relevance to tolcapone liver toxicity . Chem. Res. Toxicol. , 16 : 123 – 128 .
- Learmonth , D. A. , Palma , P. N. , Vieira‐Coelho , M. A. and Soares‐da‐Silva , P. 2004 . Synthesis, biological evaluation, and molecular modeling studies of a novel, peripherally selective inhibitor of catechol‐O‐methyltransferase . J. Med. Chem. , 47 : 6207 – 6217 .
- Learmonth , D. A. , Bonifácio , M. J. and Soares‐da‐Silva , P. 2005 . Synthesis and biological evaluation of a novel series of “ortho‐nitrated” inhibitors of catechol‐O‐methyltransferase . J. Med. Chem. , 48 : 8070 – 8078 .
- Bernauer , K. , Borgulya , J. , Bruderer , H. , DaPrada , M. and Zürcher , G. 3,5‐Disubstituierte pyrocatecholderivate . EP Patent 237, 929 . 1987 .
- Bernauer , K. , Borgulya , J. , Bruderer , H. , DaPrada , M. and Zürcher , G. Catechol derivatives . US Patent 5, 236, 952 . 1993 .
- Learmonth , D. A. , Vieira‐Coelho , M. A. , Benes , J. , Alves , P. C. , Borges , N. and Freitas , A. P. 2002 . Soares‐da‐Silva, P. Synthesis of 1‐(3,4‐dihydroxy‐5‐nitrophenyl)‐2‐phenyl‐ethanone and derivatives as potent and long‐acting peripheral inhibitors of caterchol‐O‐methyltransferase . J. Med. Chem. , 45 : 685 – 695 .
- de Graauw , C. F. , Peters , J. A. , van Bekkum , H. and Huskens , J. 1994 . Meerwein–Ponndorf–Verley reductions and Oppenauer oxidations: an integrated approach . Synthesis , : 1007 – 1017 .
- Learmonth , D. A. and Alves , P. C. 2002 . Improved method for demethylation of nitro‐catechol methyl ethers . Synth. Commun. , 32 : 641 – 649 .